|
Charles
|
Charles Schoch offered assistance to venture-backed startups in the biotech sector.Lexington, MarylandExperienced in corporate purchasing, finance, and operations management, Charles Schoch has worked primarily with firms in the biotechnology sector. He graduated cum laude from Elon University in North Carolina in 2006, earning a degree in business and finance. Charles Schoch joined Codon Devices, Inc., in Cambridge, Massachusetts, that year, taking a position as Manager of Labs, Facilities, and Purchasing. His responsibilities with the biotech firm involved setting up accounting systems that efficiently tracked assets and managed accounts receivable and payable. Charles Schoch worked closely with the firm’s Senior Vice President of Technical Operations, developing presentation and technical report materials for meetings with investors and prospective strategic alliance partners. His duties extended to the identification, negotiation, and setup of a state-of-the-art BIOFAB laboratory. Codon Devices used the lab in developing its synthetic-biology focused products and services, including improved vaccines, engineered gene libraries, bioengineered agricultural products, and bioengineered cells that produced novel drugs. From 2008 to 2011, Charles Schoch pursued financial and operational consulting engagements in Cambridge as founder and Lead Consultant with Biops LLC. Working with venture-backed startup clients such as Eleven Biotherapeutics, Constellation Pharmaceuticals, BlueBird Bio, and Foundation Medicine, he developed financial, operational, and purchasing management systems. Charles Schoch designed and maintained procurement systems with COUPA and Excel software, automating purchasing and providing critical reporting functions. He also developed integrated financial systems employing Quickbooks and GreatPlains accounting software. Working alongside client firm CFOs and controllers, Charles Schoch reported to senior management on corporate financial positions. His scope of responsibilities extended to negotiating service and supply pricing, often at discounts of 10 to 35 percent. Mr. Schoch additionally took advantage of the combined purchasing leverage of client companies, arranging discounted pricing agreements with multiple vendors. Throughout his years consulting and working within the biotech industry, Charles Schoch has engaged closely with senior management teams, investors, and scientists in a wide array of biotech specializations. Charles Schoch's Schools
Charles Schoch's Companies
Charles Schoch's Publications
|

